410 filings
Page 4 of 21
8-K
n0t3yw
1 Dec 21
CaldolorĀ® Now Fda Approved
12:00am
8-K
9uxoh 6x1wxta1phkpk
19 Nov 21
Entry into a Material Definitive Agreement
5:17pm
8-K
9yf07pmz3dfy v2a
9 Nov 21
Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update
5:23pm
8-K
1badf 48r8si
1 Nov 21
Entry into a Material Definitive Agreement
5:25pm
8-K
rioijyqkdo9
10 Aug 21
Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update
5:15pm
8-K
tlde4a2y41
14 Jun 21
Entry into a Material Definitive Agreement
5:15pm
8-K
ac6mibzpecc3ujqxk
14 May 21
Departure of Directors or Certain Officers
5:15pm
8-K
cund14y
11 May 21
Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
5:15pm
8-K
y2o12r
30 Apr 21
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
y431of4js
9 Mar 21
Reports 9% Revenue Growth In 2020
5:15pm
EFFECT
nq0aq0p2
11 Jan 21
Notice of effectiveness
12:16am
CORRESP
fq5vm6n3mslqfl lxsz
6 Jan 21
Correspondence with SEC
12:00am
UPLOAD
1yvr2jttyuq4p8yf
16 Dec 20
Letter from SEC
12:00am
8-K
9t633
10 Dec 20
Other Events
5:18pm